Studies suggest that MDM2 is overexpressed in multiple human cancers [2], including breast cancer (15%), glioblastoma (14%), sarcomas (20%), and acute myeloid leukemia (AML), and has been shown to promote metastasis in some cancers [8,9,10,11]. Here, MDM2 is linked to acute myeloid leukemia.